Articles

Viewpoint

10.4244/EIJ-E-25-00017 May 16, 2025
Restoring Europe's global position in medical device innovation
Gilard M, Prendergast B, Wijns W, Baumbach A, Maisano F, of the PCR Board o
free

State-of-the-Art

10.4244/EIJ-D-23-00915 May 16, 2025
Treatment of patent foramen ovale
Pristipino C, Carroll J, Mas J, Wunderlich N, Søndergaard L
free

Expert Review

10.4244/EIJ-D-24-00972 May 16, 2025
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation
Goel S, Tanner R, Chan K, Khan J, Vinayak M, Lerakis S, Safi L, Khera S, Krishnamoorthy P, Kini A, Sharma S, Dangas G, Tang G

Original Research

10.4244/EIJ-D-24-00662 May 16, 2025
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry
Giannini C, Capodanno D, Toth G, Windecker S, Schüpke S, Blackman D, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli A, Schmidt A, De Backer O, Gilard M, Curtis E, L’Official G, Donal E, Laroche C, Prendergast B, Petronio A, the European Valve Durability TAVI Registry investigators o

Original Research

10.4244/EIJ-D-24-00973 May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial
Gitto M, Baber U, Sartori S, Vogel B, Angiolillo D, Briguori C, Cohen D, Collier T, Dudek D, Oliva A, Escaned J, Feng Y, Gibson C, Han Y, Di Muro F, Shlofmitz R, Huber K, Steg P, Sharma S, Sardella G, Kastrati A, Kaul U, Kornowski R, Kunadian V, Stefanini G, Mehta S, Dangas G, Mehran R

Original Research

10.4244/EIJ-D-24-00757 May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry
Gargiulo G, Cirillo P, Sperandeo L, Castiello D, Manzi L, Forzano I, Florimonte D, Simonetti F, Canonico M, Avvedimento M, Paolillo R, Spinelli A, Buongiorno F, Serafino L, Spaccarotella CAM, Franzone A, Piccolo R, Stabile E, Valgimigli M, Esposito G

Trial Design

10.4244/EIJ-D-24-00829 May 16, 2025
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
Paradies V, Van Mieghem N, Oemrawsingh R, Richardt G, Esposito G, Campo G, Burzotta F, Canova P, Linke A, Porto I, Trabattoni D, Teeuwen K, Adriaenssens T, Kala P, Stankovic G, Vliet R, Giacoppo D, Daemen J, Smits P

Research Correspondence

10.4244/EIJ-D-24-00911 May 16, 2025
Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial
Kim J, Hong S, Lim S, Cha J, Joo H, Park J, Yu C, Lim D, Kang D, Ahn J, Park D, Park S

Flashlight

10.4244/EIJ-D-24-00429 May 16, 2025
Transcaval access with an IVUS-assisted aorta-outward puncture
Muñoz Bravo J, Aguasca G, Goena A, García V, Monastyrski A, Gotarda N, Irurueta I, Creus B, Pujol Y, del Blanco B

EAPCI Column

May 16, 2025
EAPCI at EuroPCR 2025
free

Editorial

10.4244/EIJ-E-25-00016 May 5, 2025
Timing of mechanical treatments for acute pulmonary embolism: earlier is better
Lang I
free

Editorial

10.4244/EIJ-E-25-00012 May 5, 2025
Can a CT scan characterise and predict HALT evolution?
Tirado-Conte G, Nombela-Franco L
free
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved